|
Name: Hydroxypethidine
Type: Opioid
AKA: N/A
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
Hydroxypethidine, a derivative of pethidine (meperidine), was developed in the 1970s. It was studied for its analgesic properties and potential as an alternative to other opioids. Its use has been limited due to the development of newer opioids.
|
|
V. Legal Information
Hydroxypethidine, an opioid derivative, is classified as a controlled substance in many jurisdictions due to its potential for abuse. Its legal status focuses on managing opioid use and preventing misuse.
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Hydroxypethidine is a synthetic opioid derivative used for pain relief. It causes sedation and respiratory depression, acting as a downer. Short-term use is effective for managing pain, but long-term use can lead to addiction, tolerance, and severe health issues. Overdose risks include fatal respiratory depression. Safe use requires strict dosing and medical supervision. Recent research focuses on its analgesic properties and compares its risks with other opioids.  |
|
VII. Psychological Effects
Hydroxypethidine, an opioid, impacts opioid receptors to produce analgesia and mood alteration. Immediate effects include euphoria and cognitive impairment, while long-term use may lead to dependence and psychological issues. Research focuses on its efficacy and safety.
 |
|
VIII. Culture
Hydroxypethidine is a synthetic opioid providing pain relief and sedation, classifying it as a downer. Short-term use alleviates severe pain, while long-term use can lead to dependence and tolerance. Overdose is highly possible, causing respiratory depression and potentially fatal outcomes. Safe dosages are medically prescribed, typically under 100 mg per day. Recent research stresses the need for cautious prescribing to avoid addiction. Physical effects include drowsiness, constricted pupils, and reduced pain sensation.
 |